Skip to main content
About Us > Jason E. Barkeloo

Jason E. Barkeloo

Chairman & Founder

Jason E. Barkeloo is the Chairman and Founder of Open Therapeutics. His motto is, “It’s not why we can’t. It’s how we can.” Barkeloo is a serial entrepreneur with a strong reputation for building sound businesses and transitioning them to professional management. Having transitioned Open Therapeutics to a professional management team, Barkeloo continues to remain involved in Open Therapeutics from a strategic perspective.

His two enterprises prior to Open Therapeutics include Pilus Energy, a synthetic bacterial based platform which he sold to a reputable company, and Somatic Digital, a human/computer interface company that developed the Touch User Interface (TUI). His entrepreneurial ventures include several technologies for education and financial services. Mr. Barkeloo has served in the US Army both in air defense and medical laboratory operations. He has a Bachelor of Arts from The Ohio State University, a Master of Arts in Education specializing in sciences and social studies from the McGregor School of Antioch University, and Ph.D. coursework in Leadership and Organizational Change from Antioch University.

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is pushing forward research that ordinarily would not generate a public value while particularly helping underserved scientists to collaborate.

How open science helps researchers succeed
Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers. We review literature demonstrating that open research is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open research practices bring significant benefits to researchers relative to more traditional closed practices.